Aspen Aerogels, Inc. (NYSE:ASPN) Receives $19.11 Average PT from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have earned an average recommendation of “Buy” from the ten analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $19.11.

Several equities analysts have recently commented on the stock. TD Cowen raised shares of Aspen Aerogels to a “strong-buy” rating in a report on Tuesday. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Craig Hallum cut their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Finally, Roth Mkm dropped their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock opened at $6.92 on Tuesday. The stock’s fifty day moving average is $10.33 and its 200 day moving average is $16.31. Aspen Aerogels has a one year low of $6.70 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a market cap of $567.44 million, a P/E ratio of 43.22 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Sell-side analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently added to or reduced their stakes in the stock. Abbot Financial Management Inc. raised its stake in shares of Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company’s stock valued at $359,000 after acquiring an additional 1,146 shares in the last quarter. Franklin Resources Inc. raised its position in Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after purchasing an additional 1,483 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Aspen Aerogels by 3.5% in the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock worth $604,000 after buying an additional 1,724 shares during the period. Greenwood Capital Associates LLC lifted its holdings in shares of Aspen Aerogels by 5.0% in the 4th quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock worth $439,000 after buying an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC grew its position in shares of Aspen Aerogels by 6.3% during the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock worth $425,000 after buying an additional 2,118 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.